Nanostructure of Clustered DNA Damage in Leukocytes after In-Solution Irradiation with the Alpha Emitter Ra-223.
DNA repair
DSB focus substructure
Single Molecule Localization Microscopy (SMLM)
complex DNA damage
high LET irradiation
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
26 Nov 2019
26 Nov 2019
Historique:
received:
01
10
2019
revised:
22
11
2019
accepted:
23
11
2019
entrez:
30
11
2019
pubmed:
30
11
2019
medline:
30
11
2019
Statut:
epublish
Résumé
Cancer patients are increasingly treated with alpha-particle-emitting radiopharmaceuticals. At the subcellular level, alpha particles induce densely spaced ionizations and molecular damage. Induction of DNA lesions, especially clustered DNA double-strand breaks (DSBs), threatens a cell's survival. Currently, it is under debate to what extent the spatial topology of the damaged chromatin regions and the repair protein arrangements are contributing. Super-resolution light microscopy (SMLM) in combination with cluster analysis of single molecule signal-point density regions of DSB repair markers was applied to investigate the nano-structure of DNA damage foci tracks of Ra-223 in-solution irradiated leukocytes. Alpha-damaged chromatin tracks were efficiently outlined by γ-H2AX that formed large (super) foci composed of numerous 60-80 nm-sized nano-foci. Alpha damage tracks contained 60-70% of all γ-H2AX point signals in a nucleus, while less than 30% of 53BP1, MRE11 or p-ATM signals were located inside γ-H2AX damage tracks. MRE11 and p-ATM protein fluorescent tags formed focal nano-clusters of about 20 nm peak size. There were, on average, 12 (± 9) MRE11 nanoclusters in a typical γ-H2AX-marked alpha track, suggesting a minimal number of MRE11-processed DSBs per track. Our SMLM data suggest regularly arranged nano-structures during DNA repair in the damaged chromatin domain.
Sections du résumé
BACKGROUND
BACKGROUND
Cancer patients are increasingly treated with alpha-particle-emitting radiopharmaceuticals. At the subcellular level, alpha particles induce densely spaced ionizations and molecular damage. Induction of DNA lesions, especially clustered DNA double-strand breaks (DSBs), threatens a cell's survival. Currently, it is under debate to what extent the spatial topology of the damaged chromatin regions and the repair protein arrangements are contributing.
METHODS
METHODS
Super-resolution light microscopy (SMLM) in combination with cluster analysis of single molecule signal-point density regions of DSB repair markers was applied to investigate the nano-structure of DNA damage foci tracks of Ra-223 in-solution irradiated leukocytes.
RESULTS
RESULTS
Alpha-damaged chromatin tracks were efficiently outlined by γ-H2AX that formed large (super) foci composed of numerous 60-80 nm-sized nano-foci. Alpha damage tracks contained 60-70% of all γ-H2AX point signals in a nucleus, while less than 30% of 53BP1, MRE11 or p-ATM signals were located inside γ-H2AX damage tracks. MRE11 and p-ATM protein fluorescent tags formed focal nano-clusters of about 20 nm peak size. There were, on average, 12 (± 9) MRE11 nanoclusters in a typical γ-H2AX-marked alpha track, suggesting a minimal number of MRE11-processed DSBs per track. Our SMLM data suggest regularly arranged nano-structures during DNA repair in the damaged chromatin domain.
Identifiants
pubmed: 31779276
pii: cancers11121877
doi: 10.3390/cancers11121877
pmc: PMC6966434
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : SCHE350/12-2
Organisme : Deutsche Forschungsgemeinschaft
ID : LA 2304/3-2
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.
Références
Nucleic Acids Res. 2013 Jul;41(12):6109-18
pubmed: 23620287
Int J Radiat Oncol Biol Phys. 1996 Feb 1;34(3):599-608
pubmed: 8621284
J Cell Biol. 2006 Apr 24;173(2):195-206
pubmed: 16618811
PLoS One. 2011;6(7):e22678
pubmed: 21818365
Science. 2004 Jan 2;303(5654):92-5
pubmed: 14704429
Mutat Res. 2010 Apr-Jun;704(1-3):88-100
pubmed: 20144732
EMBO J. 2010 Apr 21;29(8):1446-57
pubmed: 20360682
Nanoscale. 2018 Mar 1;10(9):4320-4331
pubmed: 29443341
Radiat Res. 2011 Dec;176(6):706-15
pubmed: 21797665
Cell Cycle. 2005 Jun;4(6):838-45
pubmed: 15846060
Nanoscale. 2018 Jan 18;10(3):1162-1179
pubmed: 29271466
Nat Methods. 2014 Mar;11(3):253-66
pubmed: 24577276
Int J Mol Sci. 2017 Sep 28;18(10):null
pubmed: 28956810
Mol Cell. 2017 Sep 7;67(5):891-898.e4
pubmed: 28867292
Cancer Lett. 2013 May 28;332(2):237-48
pubmed: 22261329
Mutat Res. 2019 Nov;816-818:111675
pubmed: 31302572
Cancers (Basel). 2017 Jul 18;9(7):null
pubmed: 28718816
DNA Repair (Amst). 2011 Apr 3;10(4):427-37
pubmed: 21342792
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
J Natl Cancer Inst. 2015 Dec 18;108(5):null
pubmed: 26683407
Int J Cancer. 2012 Mar 1;130(5):991-1000
pubmed: 21935920
Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2199-206
pubmed: 26116906
Semin Cancer Biol. 2016 Jun;37-38:51-64
pubmed: 27016036
Radiat Prot Dosimetry. 2006;122(1-4):124-7
pubmed: 17351270
Int J Mol Sci. 2017 Feb 09;18(2):
pubmed: 28208769
FASEB J. 2016 Aug;30(8):2767-76
pubmed: 27166088
Sci Rep. 2016 Dec 06;6:38295
pubmed: 27922110
Nat Cell Biol. 2007 Nov;9(11):1311-8
pubmed: 17952060
Nature. 2003 Jan 30;421(6922):499-506
pubmed: 12556884
Mech Ageing Dev. 2009 Nov-Dec;130(11-12):784-92
pubmed: 19896964
Radiat Environ Biophys. 2006 Nov;45(4):267-76
pubmed: 17047977
Nanoscale. 2015 Nov 14;7(42):17938-46
pubmed: 26463479
Nucleic Acids Res. 2011 Aug;39(15):6489-99
pubmed: 21511815
Int J Mol Sci. 2017 May 07;18(5):null
pubmed: 28481278
FASEB J. 2018 Jun 12;:fj201701435
pubmed: 29894665
Mutagenesis. 2010 May;25(3):289-97
pubmed: 20167590
Nucleic Acids Res. 2013 Sep;41(16):7589-605
pubmed: 23804754
J Radiat Res. 2011;52(3):309-19
pubmed: 21628845
Nanoscale. 2019 Aug 1;11(30):14226-14236
pubmed: 31317161
Nat Cell Biol. 2010 Feb;12(2):177-84
pubmed: 20081839
Int J Mol Sci. 2018 Aug 02;19(8):null
pubmed: 30072594
Int J Mol Sci. 2018 Nov 22;19(12):null
pubmed: 30469529
Radiother Oncol. 2016 Oct;121(1):154-161
pubmed: 27637859
Sci Rep. 2018 Feb 2;8(1):2286
pubmed: 29396412
Nat Methods. 2008 Mar;5(3):261-6
pubmed: 18309310
Nanoscale. 2016 Dec 28;8(48):20037-20047
pubmed: 27883139
Nat Commun. 2017 Jun 12;8:15760
pubmed: 28604675
Free Radic Biol Med. 2017 Jun;107:125-135
pubmed: 27939934
Radiother Oncol. 2018 Dec;129(3):600-610
pubmed: 30049456
Cell. 2004 Sep 17;118(6):699-713
pubmed: 15369670
Cancers (Basel). 2018 Jan 22;10(1):null
pubmed: 29361783
Free Radic Res. 2016 Nov;50(sup1):S64-S78
pubmed: 27593437
Clin Oncol (R Coll Radiol). 2014 May;26(5):243-9
pubmed: 24630811
PLoS One. 2012;7(6):e39521
pubmed: 22761813
Biochem Biophys Res Commun. 2014 Oct 3;452(4):1034-9
pubmed: 25240135
Phys Med. 2001;17 Suppl 1:217-8
pubmed: 11776277
Mutat Res. 2012 Oct-Dec;751(2):158-246
pubmed: 22743550
Radiat Prot Dosimetry. 2002;99(1-4):63-8
pubmed: 12194362
Curr Med Chem. 2018;25(23):2722-2735
pubmed: 29484975
Radiat Environ Biophys. 2008 Nov;47(4):423-9
pubmed: 18648839
Nat Rev Mol Cell Biol. 2011 Feb;12(2):90-103
pubmed: 21252998
Radiat Res. 2013 Jul;180(1):100-9
pubmed: 23682596
Trends Biochem Sci. 2017 Sep;42(9):690-701
pubmed: 28739276
J Nucl Med. 2010 Feb;51(2):311-28
pubmed: 20080889
Biophys J. 2010 Sep 8;99(5):1358-67
pubmed: 20816047
J Cell Biol. 1999 Sep 6;146(5):905-16
pubmed: 10477747
DNA Repair (Amst). 2018 Nov;71:164-171
pubmed: 30177438
Rev Esp Med Nucl Imagen Mol. 2018 Sep - Oct;37(5):330-337
pubmed: 29661653
PLoS One. 2014 Feb 03;9(2):e87458
pubmed: 24498326
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Clin Cancer Res. 2014 Jan 1;20(1):9-14
pubmed: 24190979
PLoS One. 2015 Jun 04;10(6):e0128555
pubmed: 26042422
J Microsc. 2009 Aug;235(2):163-71
pubmed: 19659910
Sci Rep. 2017 Jan 17;7:40616
pubmed: 28094292
DNA Repair (Amst). 2015 Apr;28:93-106
pubmed: 25659339
EJNMMI Res. 2018 Aug 6;8(1):77
pubmed: 30083998